Elekta

Report Publication Announcement • Nov 14, 2014

Conference call regarding Elekta's half-year report for 2014/15

STOCKHOLM, November 14, 2014 – Elekta (EKTA-B.ST) will publish its half year report, 2014/15 on November 27, as per:

• The report will be published at 07:30 CET.
• Elekta will host a telephone conference at 10:00-11:00 CET with Niklas Savander, President and CEO and Håkan Bergström, CFO.

To take part in the conference call, please dial in about five minutes in advance, use the telephone numbers below.

• UK dial-in number: +44 20 766 02077
• US dial-in number: +1 855 716 1592
• Swedish dial-in number: +46 8 519 99 030

The telephone conference will be broadcasted live online (for the possibility to ask questions, please also dial in). Please use the link:

http://event.onlineseminarsolutions.com/r.htm?e=884167&s=1&k=DAD0804CEF34CCB8EB5 838290FD20DDB

#

For further information, please contact:

Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 15:30 CET on November 14, 2014.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resourceefficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.